Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Misonix, Inc. (NasdaqGS: MSON) to Bioventus Inc. (Nasdaq: BVS). Under the terms of the proposed transaction, shareholders of Misonix may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (
[email protected]
) toll free at any time at 855-768-1857, or visit
https://www.ksfcounsel.com/cases/nasdaqgs-mson/
to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit
www.ksfcounsel.com
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210731005009/en/
Contacts
Lewis Kahn, Managing Partner
[email protected]
855-768-1857
The post
MISONIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Misonix, Inc. – MSON
first appeared on
Financial Buzz
.
For further details see: